Omega-3 Index

There is a nutrient your heart and brain are largely built from, that your body cannot make in any meaningful amount, and that most people in the Western world are quietly short on. It almost never gets measured, and its deficiency makes no noise until the day it matters most.

That nutrient is the marine omega-3 pair, EPA and DHA. They are woven into the membrane of every cell you own, and they are especially concentrated in the tissues that have to flex and fire without fail: the beating heart, the signaling brain, the light-sensing retina. When those membranes are well supplied, they are supple and electrically stable. When they are not, the deficit sits silent for decades.

The Omega-3 Index is the number that makes this visible. It measures the percentage of your red blood cell membranes made up of EPA and DHA, and because those membranes mirror the rest of your body and turn over slowly, it reflects your true long-term status rather than what you ate yesterday ^[1].

Here is what makes it worth testing: it is one of the easiest numbers on any panel to move.

EPA and DHA are long-chain omega-3 fatty acids, and the body's ability to make them from scratch is almost nonexistent. The plant omega-3 found in flax and walnuts, ALA, can in theory be converted to EPA and DHA, but the conversion is so inefficient, often under a few percent, that it cannot reliably supply what the tissues need. For practical purposes, EPA and DHA come from the diet, and overwhelmingly from marine sources: oily fish, and the algae the fish get them from in the first place.

Once absorbed, they are incorporated directly into the phospholipids of cell membranes, where they do several jobs at once. They keep membranes fluid, which matters for how receptors, channels, and transporters work. In heart tissue they stabilize the ion channels that govern the electrical rhythm, which is the leading explanation for their link to a lower rate of fatal arrhythmia. And they serve as the raw material for a family of signaling molecules called specialized pro-resolving mediators, the resolvins and protectins, which the body uses to actively shut inflammation down rather than merely suppress it ^[2].

Because red blood cells live about four months and their membranes turn over on that timescale, the Omega-3 Index is a slow, stable average rather than a snapshot. A single salmon dinner barely moves it. This is its strength: it reads tissue status, not the last meal, much the way HbA1c reads months of blood sugar rather than this morning's reading.

The index was introduced as a risk marker with proposed targets that have held up well: above 8% is associated with low cardiovascular risk, below 4% with high risk, and the broad middle is intermediate ^[1]. The trouble is where most people land. Typical Western values cluster around 4 to 5%, near the high-risk end, while populations that eat a lot of marine food, such as Japan, sit comfortably above 8% and have correspondingly lower rates of sudden cardiac death.

The mortality data is what elevates this from a lipid curiosity to a longevity marker. In a pooled analysis of 17 cohorts following more than 40,000 people, a higher Omega-3 Index predicted lower risk of death from all causes, from cardiovascular disease, and from cancer, with the largest gap between the lowest and highest groups ^[3]. In the Framingham cohort, the red blood cell fatty acid profile predicted all-cause mortality about as well as the traditional risk factors clinicians already track, and a low omega-3 status carried a reduction in life expectancy in the same conversation as smoking ^[4].

The honest caveat is about supplements specifically. Raising omega-3 status is clearly beneficial, but the trial evidence for capsules is more mixed than the marketing suggests: meta-analysis finds a modest, dose-dependent reduction in cardiovascular events, strongest for coronary endpoints, while some large low-dose primary-prevention trials came back largely neutral ^[5]. The cleanest way to read all of it: the Omega-3 Index is a robust marker of risk, food is the first-line way to raise it, and supplements are a reasonable tool when intake is low, with the strongest signal for cardiac rhythm, triglycerides, and inflammation rather than for curing everything.